Iberia Pharmaceuticals is establishing a modern skincare manufacturing and research plant in Jhajjar Haryana, a significant first step to enhance its presence in India in the skincare sector. The modern unit will include 60,000 sq. ft. and...
In Nobeoka City, Miyazaki, Japan, Asahi Kasei Life Science, a branch of the multifaceted international manufacturer Asahi Kasei, revealed intentions to build a new spinning mill for its Planova virus elimination filters
In a momentous advancement for lung cancer care in Ghana, AstraZeneca and Revna Biosciences have renewed their commitment to improve access to diagnosis and treatment. Building on a strategic initiative announced in April 2025, this undertaking...
Hyderabad pharmaceutical company Aurobindo Pharma said on July 30 that its US-based unit, Aurobindo Pharma USA Inc., has signed a binding agreement to buy Lannett Company LLC
Reinforcing its commitment to preventive oncology for women, Apollo Cancer Centres (ACCs) today launched End-O Check, a comprehensive early detection program targeting women aged 45 and above...
Everest Group, a leading global research and consulting firm, named Indegene a Leader in Life Sciences AI and Analytics Services for Commercial PEAK Matrix Assessment 2025. Everest Group acknowledged Indegene’s wide-ranging AI and Analytics...
The Kingdom of Saudi Arabia (KSA) is contacting Indian pharmaceutical and medical device businesses for strategic partnerships and investment in its quickly growing healthcare sector, which is a significant step towards strengthening bilateral
In an increasing threat to India’s medtech industry, imported medical devices are now facing pressure of being sold at inflated high Maximum Retail Prices (MRPs) or without adequately disclosed prices. Indigenous manufacturers of medical devices...
The much-proposed 25% general tariff, which US President Donald Trump revealed on August 1, 2025, will exempt Indian drug exports to the US. But the mood is far from festive.
Merck & Co. has initiated a major cost-cutting program that will save $3 billion by 2027. The multiyear program of optimization, outlined in its Q2 2025 earnings announcement
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")